Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

NCT02740777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus
Cervical Intraepithelial Neoplasia
Persistent Infection

Interventions

BIOLOGICAL: HPV-16/18 vaccine

Sponsor

Shanghai Zerun Biotechnology Co.,Ltd

Collaborators

[object Object]